Furthermore, miR224 binds to the Smad4 and Homeobox D10 (HOXD10) to promote migration of HCC and CRC [8, 12] while it binds to the TPD52 to inhibit migration of prostatic cancer PCa cells [13]. Here, SMAD4 is linked to prostate carcinoma.